Effectiveness of Herbal Medicine for Leukopenia/Neutropenia Induced by Chemotherapy in Adults with Colorectal Cancer: A Systematic Review and Meta-analysis

Author:

Yan Shao-Hua1ORCID,Feng Shuo23,Xu Yun1ORCID,Yan Yun-Zi4,He Bin1,Sun Ling-Yun1ORCID,Pang Bing5,Liu Wen-Jia6,Xu Yu-Ying4,Zhao Na4,Tang Mo1,Chen Yue4,Yu Ming-Kun4,Yang Yu-Fei1

Affiliation:

1. Xiyuan Hospital,China Academy of Chinese Medical Sciences, Beijing, China

2. Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China

3. Beijing Institute of Traditional Chinese Medicine, Beijing, China

4. Beijing University of Chinese Medicine, Beijing, China

5. Guang’anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China

6. The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China

Abstract

Objective: To evaluate the effectiveness of Chinese Herbal Medicine (CHM) on leukopenia/neutropenia induced by chemotherapy in adults with colorectal cancer (CRC). Methods: Eight electronic databases were searched from their inception to June 2020. Randomized controlled trials with clarified sequence generation were qualified. Two reviewers independently conducted the screening and data extraction. Methodological quality was assessed using the Risk of Bias tool. RevMan 5.4 was applied to the meta-analysis. Results: Twenty-seven studies involving 1867 participants were qualified, of which 26 were included in the quantitative synthesis. Meta-analysis showed that CHM significantly reduced the incidence of leukopenia induced by chemotherapy (RR = 0.69; 95% CI 0.59-0.82), as well as the grade 3/4 leukopenia (RR = 0.71; 95% CI 0.55-0.90). Meanwhile,CHM decreased the occurrence of neutropenia (RR = 0.52, 95% CI 0.35-0.77), especially for the grades 3/4 neutropenia (RR = 0.42, 95% CI 0.27-0.64). Twenty-six of the included studies focused on the adverse events related to CHM. Conclusion: CHM may relieve neutropenia/leukopenia induced by chemotherapy in adults with colorectal cancer.

Funder

national key research and development program of china

china academy of chinese medical sciences

Publisher

SAGE Publications

Subject

Complementary and alternative medicine,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3